ARCHIVES

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

This article is from The Cancer Letter archive.

Vol. 29 No. 46 | December 12, 2003

Download PDF Visit The Full Archive

Related Articles

NCAB Hears “Impressive” Progress Reports, Including Treatment for Breast, Liver Cancer, Vaccine Studies

October 18, 1974

Cancer Education: NCI Offers Training In Epidemiology And Genetics

April 17, 1998

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

Letter: A Modest Proposal To Abolish FDA

January 26, 1996

ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust

May 27, 1994

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

April 29, 1994